PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
As the global economy mends, the 2021 growth of Covid-19 Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Covid-19 Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Covid-19 Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period. The United States Covid-19 Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Covid-19 Vaccine market, reaching US$ million by the year 2028. As for the Europe Covid-19 Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period. Global main Covid-19 Vaccine players cover Inovio Pharmaceuticals, Takis Biotech (Evvivax), Zydus Cadila, and Codagenix, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. This report presents a comprehensive overview, market shares, and growth opportunities of Covid-19 Vaccine market by product type, application, key players and key regions and countries. Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7. DNA Live Attenuated Virus NonReplicating Viral Vecto Protein Subunit RNA Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8. Treatment Prevention This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3. Inovio Pharmaceuticals Takis Biotech (Evvivax) Zydus Cadila Codagenix, Inc. GeoVax, Inc. Bravovax Janssen Pharmaceutical Companies Altimmune Vaxart CanSino Biologics ExpreS2ion Biotechnologies ApS Clover Biopharmaceuticals GSK Vaxil Bio Ltd. Generex Novavax, Inc. Sanofi Pasteur Baylor iBio, Inc. Zydus Cadila Moderna, Inc. Curevac ImmunoPrecise
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Covid-19 Vaccine Market Size 2017-2028
2.1.2 Covid-19 Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Covid-19 Vaccine Segment by Type
2.2.1 DNA
2.2.2 Live Attenuated Virus
2.2.3 NonReplicating Viral Vecto
2.2.4 Protein Subunit
2.2.5 RNA
2.3 Covid-19 Vaccine Market Size by Type
2.3.1 Covid-19 Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Covid-19 Vaccine Market Size Market Share by Type (2017-2022)
2.4 Covid-19 Vaccine Segment by Application
2.4.1 Treatment
2.4.2 Prevention
2.5 Covid-19 Vaccine Market Size by Application
2.5.1 Covid-19 Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Covid-19 Vaccine Market Size Market Share by Application (2017-2022)
3 Covid-19 Vaccine Market Size by Player
3.1 Covid-19 Vaccine Market Size Market Share by Players
3.1.1 Global Covid-19 Vaccine Revenue by Players (2020-2022)
3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2020-2022)
3.2 Global Covid-19 Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Covid-19 Vaccine by Regions
4.1 Covid-19 Vaccine Market Size by Regions (2017-2022)
4.2 Americas Covid-19 Vaccine Market Size Growth (2017-2022)
4.3 APAC Covid-19 Vaccine Market Size Growth (2017-2022)
4.4 Europe Covid-19 Vaccine Market Size Growth (2017-2022)
4.5 Middle East & Africa Covid-19 Vaccine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Covid-19 Vaccine Market Size by Country (2017-2022)
5.2 Americas Covid-19 Vaccine Market Size by Type (2017-2022)
5.3 Americas Covid-19 Vaccine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covid-19 Vaccine Market Size by Region (2017-2022)
6.2 APAC Covid-19 Vaccine Market Size by Type (2017-2022)
6.3 APAC Covid-19 Vaccine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Covid-19 Vaccine by Country (2017-2022)
7.2 Europe Covid-19 Vaccine Market Size by Type (2017-2022)
7.3 Europe Covid-19 Vaccine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Covid-19 Vaccine by Region (2017-2022)
8.2 Middle East & Africa Covid-19 Vaccine Market Size by Type (2017-2022)
8.3 Middle East & Africa Covid-19 Vaccine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Covid-19 Vaccine Market Forecast
10.1 Global Covid-19 Vaccine Forecast by Regions (2023-2028)
10.1.1 Global Covid-19 Vaccine Forecast by Regions (2023-2028)
10.1.2 Americas Covid-19 Vaccine Forecast
10.1.3 APAC Covid-19 Vaccine Forecast
10.1.4 Europe Covid-19 Vaccine Forecast
10.1.5 Middle East & Africa Covid-19 Vaccine Forecast
10.2 Americas Covid-19 Vaccine Forecast by Country (2023-2028)
10.2.1 United States Covid-19 Vaccine Market Forecast
10.2.2 Canada Covid-19 Vaccine Market Forecast
10.2.3 Mexico Covid-19 Vaccine Market Forecast
10.2.4 Brazil Covid-19 Vaccine Market Forecast
10.3 APAC Covid-19 Vaccine Forecast by Region (2023-2028)
10.3.1 China Covid-19 Vaccine Market Forecast
10.3.2 Japan Covid-19 Vaccine Market Forecast
10.3.3 Korea Covid-19 Vaccine Market Forecast
10.3.4 Southeast Asia Covid-19 Vaccine Market Forecast
10.3.5 India Covid-19 Vaccine Market Forecast
10.3.6 Australia Covid-19 Vaccine Market Forecast
10.4 Europe Covid-19 Vaccine Forecast by Country (2023-2028)
10.4.1 Germany Covid-19 Vaccine Market Forecast
10.4.2 France Covid-19 Vaccine Market Forecast
10.4.3 UK Covid-19 Vaccine Market Forecast
10.4.4 Italy Covid-19 Vaccine Market Forecast
10.4.5 Russia Covid-19 Vaccine Market Forecast
10.5 Middle East & Africa Covid-19 Vaccine Forecast by Region (2023-2028)
10.5.1 Egypt Covid-19 Vaccine Market Forecast
10.5.2 South Africa Covid-19 Vaccine Market Forecast
10.5.3 Israel Covid-19 Vaccine Market Forecast
10.5.4 Turkey Covid-19 Vaccine Market Forecast
10.5.5 GCC Countries Covid-19 Vaccine Market Forecast
10.6 Global Covid-19 Vaccine Forecast by Type (2023-2028)
10.7 Global Covid-19 Vaccine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Inovio Pharmaceuticals
11.1.1 Inovio Pharmaceuticals Company Information
11.1.2 Inovio Pharmaceuticals Covid-19 Vaccine Product Offered
11.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Inovio Pharmaceuticals Main Business Overview
11.1.5 Inovio Pharmaceuticals Latest Developments
11.2 Takis Biotech (Evvivax)
11.2.1 Takis Biotech (Evvivax) Company Information
11.2.2 Takis Biotech (Evvivax) Covid-19 Vaccine Product Offered
11.2.3 Takis Biotech (Evvivax) Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Takis Biotech (Evvivax) Main Business Overview
11.2.5 Takis Biotech (Evvivax) Latest Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Information
11.3.2 Zydus Cadila Covid-19 Vaccine Product Offered
11.3.3 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Zydus Cadila Main Business Overview
11.3.5 Zydus Cadila Latest Developments
11.4 Codagenix, Inc.
11.4.1 Codagenix, Inc. Company Information
11.4.2 Codagenix, Inc. Covid-19 Vaccine Product Offered
11.4.3 Codagenix, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Codagenix, Inc. Main Business Overview
11.4.5 Codagenix, Inc. Latest Developments
11.5 GeoVax, Inc.
11.5.1 GeoVax, Inc. Company Information
11.5.2 GeoVax, Inc. Covid-19 Vaccine Product Offered
11.5.3 GeoVax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GeoVax, Inc. Main Business Overview
11.5.5 GeoVax, Inc. Latest Developments
11.6 Bravovax
11.6.1 Bravovax Company Information
11.6.2 Bravovax Covid-19 Vaccine Product Offered
11.6.3 Bravovax Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bravovax Main Business Overview
11.6.5 Bravovax Latest Developments
11.7 Janssen Pharmaceutical Companies
11.7.1 Janssen Pharmaceutical Companies Company Information
11.7.2 Janssen Pharmaceutical Companies Covid-19 Vaccine Product Offered
11.7.3 Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Janssen Pharmaceutical Companies Main Business Overview
11.7.5 Janssen Pharmaceutical Companies Latest Developments
11.8 Altimmune
11.8.1 Altimmune Company Information
11.8.2 Altimmune Covid-19 Vaccine Product Offered
11.8.3 Altimmune Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Altimmune Main Business Overview
11.8.5 Altimmune Latest Developments
11.9 Vaxart
11.9.1 Vaxart Company Information
11.9.2 Vaxart Covid-19 Vaccine Product Offered
11.9.3 Vaxart Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Vaxart Main Business Overview
11.9.5 Vaxart Latest Developments
11.10 CanSino Biologics
11.10.1 CanSino Biologics Company Information
11.10.2 CanSino Biologics Covid-19 Vaccine Product Offered
11.10.3 CanSino Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CanSino Biologics Main Business Overview
11.10.5 CanSino Biologics Latest Developments
11.11 ExpreS2ion Biotechnologies ApS
11.11.1 ExpreS2ion Biotechnologies ApS Company Information
11.11.2 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Product Offered
11.11.3 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 ExpreS2ion Biotechnologies ApS Main Business Overview
11.11.5 ExpreS2ion Biotechnologies ApS Latest Developments
11.12 Clover Biopharmaceuticals
11.12.1 Clover Biopharmaceuticals Company Information
11.12.2 Clover Biopharmaceuticals Covid-19 Vaccine Product Offered
11.12.3 Clover Biopharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Clover Biopharmaceuticals Main Business Overview
11.12.5 Clover Biopharmaceuticals Latest Developments
11.13 GSK
11.13.1 GSK Company Information
11.13.2 GSK Covid-19 Vaccine Product Offered
11.13.3 GSK Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 GSK Main Business Overview
11.13.5 GSK Latest Developments
11.14 Vaxil Bio Ltd.
11.14.1 Vaxil Bio Ltd. Company Information
11.14.2 Vaxil Bio Ltd. Covid-19 Vaccine Product Offered
11.14.3 Vaxil Bio Ltd. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Vaxil Bio Ltd. Main Business Overview
11.14.5 Vaxil Bio Ltd. Latest Developments
11.15 Generex
11.15.1 Generex Company Information
11.15.2 Generex Covid-19 Vaccine Product Offered
11.15.3 Generex Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Generex Main Business Overview
11.15.5 Generex Latest Developments
11.16 Novavax, Inc.
11.16.1 Novavax, Inc. Company Information
11.16.2 Novavax, Inc. Covid-19 Vaccine Product Offered
11.16.3 Novavax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Novavax, Inc. Main Business Overview
11.16.5 Novavax, Inc. Latest Developments
11.17 Sanofi Pasteur
11.17.1 Sanofi Pasteur Company Information
11.17.2 Sanofi Pasteur Covid-19 Vaccine Product Offered
11.17.3 Sanofi Pasteur Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Sanofi Pasteur Main Business Overview
11.17.5 Sanofi Pasteur Latest Developments
11.18 Baylor
11.18.1 Baylor Company Information
11.18.2 Baylor Covid-19 Vaccine Product Offered
11.18.3 Baylor Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Baylor Main Business Overview
11.18.5 Baylor Latest Developments
11.19 iBio, Inc.
11.19.1 iBio, Inc. Company Information
11.19.2 iBio, Inc. Covid-19 Vaccine Product Offered
11.19.3 iBio, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 iBio, Inc. Main Business Overview
11.19.5 iBio, Inc. Latest Developments
11.20 Zydus Cadila
11.20.1 Zydus Cadila Company Information
11.20.2 Zydus Cadila Covid-19 Vaccine Product Offered
11.20.3 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Zydus Cadila Main Business Overview
11.20.5 Zydus Cadila Latest Developments
11.21 Moderna, Inc.
11.21.1 Moderna, Inc. Company Information
11.21.2 Moderna, Inc. Covid-19 Vaccine Product Offered
11.21.3 Moderna, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Moderna, Inc. Main Business Overview
11.21.5 Moderna, Inc. Latest Developments
11.22 Curevac
11.22.1 Curevac Company Information
11.22.2 Curevac Covid-19 Vaccine Product Offered
11.22.3 Curevac Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Curevac Main Business Overview
11.22.5 Curevac Latest Developments
11.23 ImmunoPrecise
11.23.1 ImmunoPrecise Company Information
11.23.2 ImmunoPrecise Covid-19 Vaccine Product Offered
11.23.3 ImmunoPrecise Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 ImmunoPrecise Main Business Overview
11.23.5 ImmunoPrecise Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Covid-19 Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions) Table 2. Major Players of DNA Table 3. Major Players of Live Attenuated Virus Table 4. Major Players of NonReplicating Viral Vecto Table 5. Major Players of Protein Subunit Table 6. Major Players of RNA Table 7. Covid-19 Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions) Table 8. Global Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions) Table 9. Global Covid-19 Vaccine Market Size Market Share by Type (2017-2022) Table 10. Covid-19 Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions) Table 11. Global Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions) Table 12. Global Covid-19 Vaccine Market Size Market Share by Application (2017-2022) Table 13. Global Covid-19 Vaccine Revenue by Players (2020-2022) & ($ Millions) Table 14. Global Covid-19 Vaccine Revenue Market Share by Player (2020-2022) Table 15. Covid-19 Vaccine Key Players Head office and Products Offered Table 16. Covid-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Covid-19 Vaccine Market Size by Regions 2017-2022 & ($ Millions) Table 20. Global Covid-19 Vaccine Market Size Market Share by Regions (2017-2022) Table 21. Americas Covid-19 Vaccine Market Size by Country (2017-2022) & ($ Millions) Table 22. Americas Covid-19 Vaccine Market Size Market Share by Country (2017-2022) Table 23. Americas Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions) Table 24. Americas Covid-19 Vaccine Market Size Market Share by Type (2017-2022) Table 25. Americas Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions) Table 26. Americas Covid-19 Vaccine Market Size Market Share by Application (2017-2022) Table 27. APAC Covid-19 Vaccine Market Size by Region (2017-2022) & ($ Millions) Table 28. APAC Covid-19 Vaccine Market Size Market Share by Region (2017-2022) Table 29. APAC Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions) Table 30. APAC Covid-19 Vaccine Market Size Market Share by Type (2017-2022) Table 31. APAC Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions) Table 32. APAC Covid-19 Vaccine Market Size Market Share by Application (2017-2022) Table 33. Europe Covid-19 Vaccine Market Size by Country (2017-2022) & ($ Millions) Table 34. Europe Covid-19 Vaccine Market Size Market Share by Country (2017-2022) Table 35. Europe Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions) Table 36. Europe Covid-19 Vaccine Market Size Market Share by Type (2017-2022) Table 37. Europe Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions) Table 38. Europe Covid-19 Vaccine Market Size Market Share by Application (2017-2022) Table 39. Middle East & Africa Covid-19 Vaccine Market Size by Region (2017-2022) & ($ Millions) Table 40. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Region (2017-2022) Table 41. Middle East & Africa Covid-19 Vaccine Market Size by Type (2017-2022) & ($ Millions) Table 42. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Type (2017-2022) Table 43. Middle East & Africa Covid-19 Vaccine Market Size by Application (2017-2022) & ($ Millions) Table 44. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Application (2017-2022) Table 45. Key Market Drivers & Growth Opportunities of Covid-19 Vaccine Table 46. Key Market Challenges & Risks of Covid-19 Vaccine Table 47. Key Industry Trends of Covid-19 Vaccine Table 48. Global Covid-19 Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions) Table 49. Global Covid-19 Vaccine Market Size Market Share Forecast by Regions (2023-2028) Table 50. Global Covid-19 Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions) Table 51. Global Covid-19 Vaccine Market Size Market Share Forecast by Type (2023-2028) Table 52. Global Covid-19 Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions) Table 53. Global Covid-19 Vaccine Market Size Market Share Forecast by Application (2023-2028) Table 54. Inovio Pharmaceuticals Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 55. Inovio Pharmaceuticals Covid-19 Vaccine Product Offered Table 56. Inovio Pharmaceuticals Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 57. Inovio Pharmaceuticals Main Business Table 58. Inovio Pharmaceuticals Latest Developments Table 59. Takis Biotech (Evvivax) Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 60. Takis Biotech (Evvivax) Covid-19 Vaccine Product Offered Table 61. Takis Biotech (Evvivax) Main Business Table 62. Takis Biotech (Evvivax) Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 63. Takis Biotech (Evvivax) Latest Developments Table 64. Zydus Cadila Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 65. Zydus Cadila Covid-19 Vaccine Product Offered Table 66. Zydus Cadila Main Business Table 67. Zydus Cadila Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 68. Zydus Cadila Latest Developments Table 69. Codagenix, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 70. Codagenix, Inc. Covid-19 Vaccine Product Offered Table 71. Codagenix, Inc. Main Business Table 72. Codagenix, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 73. Codagenix, Inc. Latest Developments Table 74. GeoVax, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 75. GeoVax, Inc. Covid-19 Vaccine Product Offered Table 76. GeoVax, Inc. Main Business Table 77. GeoVax, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 78. GeoVax, Inc. Latest Developments Table 79. Bravovax Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 80. Bravovax Covid-19 Vaccine Product Offered Table 81. Bravovax Main Business Table 82. Bravovax Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 83. Bravovax Latest Developments Table 84. Janssen Pharmaceutical Companies Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 85. Janssen Pharmaceutical Companies Covid-19 Vaccine Product Offered Table 86. Janssen Pharmaceutical Companies Main Business Table 87. Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 88. Janssen Pharmaceutical Companies Latest Developments Table 89. Altimmune Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 90. Altimmune Covid-19 Vaccine Product Offered Table 91. Altimmune Main Business Table 92. Altimmune Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 93. Altimmune Latest Developments Table 94. Vaxart Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 95. Vaxart Covid-19 Vaccine Product Offered Table 96. Vaxart Main Business Table 97. Vaxart Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 98. Vaxart Latest Developments Table 99. CanSino Biologics Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 100. CanSino Biologics Covid-19 Vaccine Product Offered Table 101. CanSino Biologics Main Business Table 102. CanSino Biologics Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 103. CanSino Biologics Latest Developments Table 104. ExpreS2ion Biotechnologies ApS Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 105. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Product Offered Table 106. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 107. ExpreS2ion Biotechnologies ApS Main Business Table 108. ExpreS2ion Biotechnologies ApS Latest Developments Table 109. Clover Biopharmaceuticals Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 110. Clover Biopharmaceuticals Covid-19 Vaccine Product Offered Table 111. Clover Biopharmaceuticals Main Business Table 112. Clover Biopharmaceuticals Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 113. Clover Biopharmaceuticals Latest Developments Table 114. GSK Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 115. GSK Covid-19 Vaccine Product Offered Table 116. GSK Main Business Table 117. GSK Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 118. GSK Latest Developments Table 119. Vaxil Bio Ltd. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 120. Vaxil Bio Ltd. Covid-19 Vaccine Product Offered Table 121. Vaxil Bio Ltd. Main Business Table 122. Vaxil Bio Ltd. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 123. Vaxil Bio Ltd. Latest Developments Table 124. Generex Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 125. Generex Covid-19 Vaccine Product Offered Table 126. Generex Main Business Table 127. Generex Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 128. Generex Latest Developments Table 129. Novavax, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 130. Novavax, Inc. Covid-19 Vaccine Product Offered Table 131. Novavax, Inc. Main Business Table 132. Novavax, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 133. Novavax, Inc. Latest Developments Table 134. Sanofi Pasteur Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 135. Sanofi Pasteur Covid-19 Vaccine Product Offered Table 136. Sanofi Pasteur Main Business Table 137. Sanofi Pasteur Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 138. Sanofi Pasteur Latest Developments Table 139. Baylor Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 140. Baylor Covid-19 Vaccine Product Offered Table 141. Baylor Main Business Table 142. Baylor Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 143. Baylor Latest Developments Table 144. iBio, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 145. iBio, Inc. Covid-19 Vaccine Product Offered Table 146. iBio, Inc. Main Business Table 147. iBio, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 148. iBio, Inc. Latest Developments Table 149. Zydus Cadila Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 150. Zydus Cadila Covid-19 Vaccine Product Offered Table 151. Zydus Cadila Main Business Table 152. Zydus Cadila Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 153. Zydus Cadila Latest Developments Table 154. Moderna, Inc. Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 155. Moderna, Inc. Covid-19 Vaccine Product Offered Table 156. Moderna, Inc. Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 157. Moderna, Inc. Main Business Table 158. Moderna, Inc. Latest Developments Table 159. Curevac Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 160. Curevac Covid-19 Vaccine Product Offered Table 161. Curevac Main Business Table 162. Curevac Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 163. Curevac Latest Developments Table 164. ImmunoPrecise Details, Company Type, Covid-19 Vaccine Area Served and Its Competitors Table 165. ImmunoPrecise Covid-19 Vaccine Product Offered Table 166. ImmunoPrecise Main Business Table 167. ImmunoPrecise Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 168. ImmunoPrecise Latest Developments List of Figures Figure 1. Covid-19 Vaccine Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Covid-19 Vaccine Market Size Growth Rate 2017-2028 ($ Millions) Figure 6. Global Covid-19 Vaccine Market Size Market Share by Type in 2021 Figure 7. Covid-19 Vaccine in Treatment Figure 8. Global Covid-19 Vaccine Market: Treatment (2017-2022) & ($ Millions) Figure 9. Covid-19 Vaccine in Prevention Figure 10. Global Covid-19 Vaccine Market: Prevention (2017-2022) & ($ Millions) Figure 11. Global Covid-19 Vaccine Market Size Market Share by Application in 2021 Figure 12. Global Covid-19 Vaccine Revenue Market Share by Player in 2021 Figure 13. Global Covid-19 Vaccine Market Size Market Share by Regions (2017-2022) Figure 14. Americas Covid-19 Vaccine Market Size 2017-2022 ($ Millions) Figure 15. APAC Covid-19 Vaccine Market Size 2017-2022 ($ Millions) Figure 16. Europe Covid-19 Vaccine Market Size 2017-2022 ($ Millions) Figure 17. Middle East & Africa Covid-19 Vaccine Market Size 2017-2022 ($ Millions) Figure 18. Americas Covid-19 Vaccine Value Market Share by Country in 2021 Figure 19. Americas Covid-19 Vaccine Consumption Market Share by Type in 2021 Figure 20. Americas Covid-19 Vaccine Market Size Market Share by Application in 2021 Figure 21. United States Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 22. Canada Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 23. Mexico Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 24. Brazil Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 25. APAC Covid-19 Vaccine Market Size Market Share by Region in 2021 Figure 26. APAC Covid-19 Vaccine Market Size Market Share by Application in 2021 Figure 27. China Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 28. Japan Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 29. Korea Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 30. Southeast Asia Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 31. India Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 32. Australia Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 33. Europe Covid-19 Vaccine Market Size Market Share by Country in 2021 Figure 34. Europe Covid-19 Vaccine Market Size Market Share by Type in 2021 Figure 35. Europe Covid-19 Vaccine Market Size Market Share by Application in 2021 Figure 36. Germany Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 37. France Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 38. UK Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 39. Italy Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 40. Russia Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 41. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Region in 2021 Figure 42. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Type in 2021 Figure 43. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Application in 2021 Figure 44. Egypt Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 45. South Africa Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 46. Israel Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 47. Turkey Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 48. GCC Country Covid-19 Vaccine Market Size Growth 2017-2022 ($ Millions) Figure 49. Americas Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 50. APAC Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 51. Europe Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 52. Middle East & Africa Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 53. United States Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 54. Canada Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 55. Mexico Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 56. Brazil Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 57. China Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 58. Japan Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 59. Korea Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 60. Southeast Asia Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 61. India Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 62. Australia Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 63. Germany Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 64. France Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 65. UK Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 66. Italy Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 67. Russia Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 68. Spain Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 69. Egypt Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 70. South Africa Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 71. Israel Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 72. Turkey Covid-19 Vaccine Market Size 2023-2028 ($ Millions) Figure 73. GCC Countries Covid-19 Vaccine Market Size 2023-2028 ($ Millions)
Inovio Pharmaceuticals Takis Biotech (Evvivax) Zydus Cadila Codagenix, Inc. GeoVax, Inc. Bravovax Janssen Pharmaceutical Companies Altimmune Vaxart CanSino Biologics ExpreS2ion Biotechnologies ApS Clover Biopharmaceuticals GSK Vaxil Bio Ltd. Generex Novavax, Inc. Sanofi Pasteur Baylor iBio, Inc. Zydus Cadila Moderna, Inc. Curevac ImmunoPrecise
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape